Gerald W. Shipps, Jr.,Clifford C. Cheng,Xioahua Huang,Abdelghani Achab,Peter Orth,Johannes H. Voigt
申请号：
US13499135
公开号：
US08759357B2
申请日:
2010.10.01
申请国别(地区):
US
年份:
2014
代理人:
摘要：
The present invention relates to novel heterocyclic compounds as Fatty Acid Binding Protein (FABP) inhibitors, pharmaceutical compositions comprising the heterocyclic compounds and the use of the compounds for treating or preventing a cardiovascular disease, a metabolic disorder, obesity or an obesity-related disorder, diabetes, dyslipidemia, a diabetic complication, impaired glucose tolerance or impaired fasting glucose. An illustrative compound of the present invention is shown below:
